SuperworthLabcorp EPS LH
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $12.09
- Latest quarter, Q2 FY26
- $3.64
- +28% on a year earlier
- Fiscal year 2025
- $10.46
- +18% on the year before
Labcorp's earnings per share was $12.09 over the twelve months to Jun 30, 2026, up 33% on a year earlier.
In its latest quarter, Q2 FY26, it was $3.64, up 28% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 8% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $10.46 | +18% |
| FY2024 | $8.83 | +90% |
| FY2023 | $4.65 | −66% |
| FY2022 | $13.85 | −43% |
| FY2021 | $24.37 | +54% |
| FY2020 | $15.82 | +89% |
| FY2019 | $8.36 | −3% |
| FY2018 | $8.60 | −27% |
| FY2017 | $11.80 | +68% |
| FY2016 | $7.01 | +65% |
| FY2015 | $4.26 | −28% |
| FY2014 | $5.93 | −5% |
| FY2013 | $6.24 | +4% |
| FY2012 | $5.98 | +18% |
| FY2011 | $5.08 | −4% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $3.64 | +28% | $12.09 | |
| Q1 FY26 | $3.35 | +33% | $11.29 | |
| Q4 FY25 | $1.98 | +16% | $10.46 | |
| Q3 FY25 | $3.12 | +56% | $10.19 | |
| Q2 FY25 | $2.84 | +17% | $9.07 | |
| Q1 FY25 | $2.52 | −6% | $8.66 | |
| Q4 FY24 | $1.71 | n/a | $8.83 | |
| Q3 FY24 | $2.00 | −5% | $5.15 | |
| Q2 FY24 | $2.43 | +15% | $5.26 | |
| Q1 FY24 | $2.69 | +13% | $4.95 | |
| Q4 FY23 | −$1.97 | −332% | $4.65 | |
| Q3 FY23 | $2.11 | −46% | $7.47 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Labcorp's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LHLabcorp | $12.09 | +33% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| ILMNIllumina | $5.38 | −32% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| WATWaters | $4.01 | −64% a year |
| IQVIQVIA | $8.06 | +17% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| BIOBio-Rad Laboratories | $8.25 | −30% a year |
| Peer median | $8.15 |
Where Labcorp ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Labcorp
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.